Processa Pharmaceuticals Inc. (PCSA) Misses Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. LRCX
6. LVS
7. SAP
8. CSX
9. KNX
10. SPY

Go back to Processa Pharmaceuticals Inc. (PCSA) Misses Q3 EPS by 1c

Processa Pharmaceuticals Announces Third Quarter 2021 Results and Provides Corporate Update

November 11, 2021 4:05 PM EST

Clinical Drug Pipeline is Funded and Targeting Major Milestones mid-2022

HANOVER, Md., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical stage company developing drugs for patients who have unmet medical conditions that require better treatment options to improve a patients survival and/or quality of life, today announces financial results for the quarter ended September 30, 2021, and provides a corporate update.

... More